Trials / Completed
CompletedNCT01132222
Bioequivalence Study of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets Under Fed Conditions
A Randomized, Open Label, 2-treatment, Single Dose, Crossover, Bioequivalence Study of Ibuprofen 200 mg+Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's and Advil® Cold and Sinus Caplets of Wyeth Consumer Healthcare Under Fed Conditions.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Dr. Reddy's Laboratories Limited · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the bioequivalence of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg under fed conditions.
Detailed description
This study assess the bioequivalence of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's and Advil® Cold and Sinus Caplets of Wyeth Consumer Healthcare in healthy human adult subjects with the single oral administration under fed conditions with a washout period of 7 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ibuprofen + Pseudoephedrine Hydrochloride | Ibuprofen 200 mg + Pseudoephedrine Hydrochloride 30 mg Tablets |
Timeline
- Start date
- 2004-09-01
- Primary completion
- 2004-10-01
- Completion
- 2004-10-01
- First posted
- 2010-05-27
- Last updated
- 2010-06-14
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT01132222. Inclusion in this directory is not an endorsement.